南京招聘

职位描述：
Responsibilities:
Responsible for the sales of PerkinElmer Informatics products, the implementation of the company's marketing strategy and sales policy, in the designated area to complete the company's sales targets;
Familiar with the product knowledge, independent completion of product demonstrations and training;
Understand customer requirements for product performance, lead time, after-sales service and training, and communicate relevant information with the responsible departments within the company to ensure the best solution / best solution to the customer. The right products, the development and implementation of sales plans to complete sales tasks;
With existing customers and target customers to establish and maintain a good long-term relationship and improve customer satisfaction; coordination with the various departments within the company operation and give product installation and customer operation training support to ensure customer satisfaction;
According to the company's channel development strategy, in the area where the development / establishment and maintenance and optimization of good business channels;
To provide distributors with sales skills and product training and counseling to help distributors reach sales targets;
Requirements:
Bachelor degree or above, preferred in clinical medicine / biomedical engineering or related field;
At least 3 years sales experience in health care IT area (experience in health care big data equipment is preferred);
Can adapt to long-term travel;
Can read e - mail in English, information and skilled operation of the computer;
Strong market development ability and excellent negotiation skills;
Good presentation skills;
With a high degree of self-motivation and teamwork capabilities;
Mature, perseverance, able to withstand the corresponding pressure;
Easy-going, good at building trust with customers. 举报 分享

珀金埃尔默（PerkinElmer，PKI）是一家具有 80 多年历史的全球性技术公司，始终致力于为创建更健康的世界而持续创新，是全球领先的医学诊断、生命科学、检测、成像、信息学和科研服务提供商。目前在全球拥有约1.3万名员工，为超过150个国家和地区提供服务。珀金埃尔默是纽交所上市公司（纽交所股票交易代码：PKI），同时也是标准普尔500指数（S&P 500 Index）中的一员。2019年度，珀金埃尔默全球范围累计收入达到28.8亿美元，在中国地区收入达20亿人民币。
作为体外诊断行业的领先企业，珀金埃尔默医学诊断产品的业务包括临床感染诊断及输血安全业务、应用基因分析业务、生殖健康及独立医学实验室业务、自身免疫和过敏性疾病诊断业务等，主要应用于遗传代谢病筛查及诊断、常规肿瘤、***（含血站系统）等免疫项目筛查，孕前、产前、新生儿及儿科等妇幼保健领域的一站式特检服务，基因组学及测序相关样本制备及数据库解决方案。
在这次抗击新型冠状病毒疫情中，珀金埃尔默***时间加入抗击疫情的工作，开展医疗物资捐赠，目前已经向湖北、黑龙江、山东、河南等地赠送用于新冠病毒检测的全自动核酸提取构建系统及试剂，总价值超过1000万人民币。同时，珀金埃尔默的中国本土团队快速反应，***时间研发出可用于血液和各种呼吸道样本检测的新型冠状病毒（COVID-19）核酸检测试剂盒，并进入了中国国家药监局注册审批程序。
2020年3月，美国食品药品管理局（FDA）已为珀金埃尔默研发的新型冠状病毒核酸检测试剂盒（RT-PCR）批准了紧急使用授权（EUA）。同时，该新型冠状病毒核酸检测试剂盒作为一种体外诊断（IVD）设备，满足欧盟体外诊断试剂指令（IVDD）的要求，并获得欧盟市场的准入资格，且于4月被正式列入WHO应急使用清单（EUL，Emergency Use Listing）。
2020年8月国际著名期刊《Nature Biotechnology》发表了关于全球获批新冠病毒核酸检测试剂盒性能对比研究：珀金埃尔默研发的核酸检测试剂盒，以0.009copies/μL最低检测限（LoD）的显著优势排名全球***，为全球最灵敏新冠病毒核酸检测试剂盒。